25 related articles for article (PubMed ID: 35245746)
1. Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.
Sengupta AK; Gunda A; Malpani S; Serkad CPV; Basavaraj C; Bapat A; Bakre MM
Cancer Med; 2020 Nov; 9(21):7810-7818. PubMed ID: 33027559
[TBL] [Abstract][Full Text] [Related]
2. CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario.
Sankaran S; Dikshit JB; Prakash Sv C; Mallikarjuna SE; Somashekhar SP; Patil S; Kumar R; Prasad K; Shet D; Bakre MM
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):21-29. PubMed ID: 33994724
[TBL] [Abstract][Full Text] [Related]
3. Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method.
Parikh P; Babu G; Singh R; Krishna V; Bhatt A; Bansal I; Rajappa S; Sahoo TP; Aggarwal S; Bapna A; Biswas G; Somashekhar SP; Bajpai J; Maniar V; Desai S; Raja T; Rath GK
BMC Cancer; 2023 Jul; 23(1):714. PubMed ID: 37525142
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.
Eshwaraiah MS; Gunda A; Kanakasetty GB; Bakre MM
Cancer Med; 2023 Jun; 12(12):13342-13351. PubMed ID: 37245224
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.
Ward S; Scope A; Rafia R; Pandor A; Harnan S; Evans P; Wyld L
Health Technol Assess; 2013 Oct; 17(44):1-302. PubMed ID: 24088296
[TBL] [Abstract][Full Text] [Related]
6. Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective.
Bhattacharyya GS; Doval DC; Desai CJ; Chaturvedi H; Sharma S; Somashekhar SP
JCO Glob Oncol; 2020 Jun; 6():789-798. PubMed ID: 32511068
[TBL] [Abstract][Full Text] [Related]
7. A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.
Gunda A; Basavaraj C; Serkad V CP; Adinarayan M; Kolli R; Siraganahalli Eshwaraiah M; Saura C; Ruiz F; Gomez P; Peg V; Jimenez J; Sprung S; Fiegl H; Brunner C; Egle D; Bhattacharyya GS; Bakre MM
Breast; 2022 Jun; 63():1-8. PubMed ID: 35245746
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.
Bakre MM; Ramkumar C; Attuluri AK; Basavaraj C; Prakash C; Buturovic L; Madhav L; Naidu N; R P; Somashekhar SP; Gupta S; Doval DC; Pegram MD
Cancer Med; 2019 Apr; 8(4):1755-1764. PubMed ID: 30848103
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin.
Chandra Doval D; Mehta A; Somashekhar SP; Gunda A; Singh G; Bal A; Khare S; Prakash V Serkad C; Adinarayan M; Krishnamoorthy N; Vijay DG; Anantakrishnan R; Bhattacharyya GS; Bakre MM
Breast; 2021 Oct; 59():1-7. PubMed ID: 34098459
[TBL] [Abstract][Full Text] [Related]
10. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.
Zhang X; Gunda A; Kranenbarg EM; Liefers GJ; Savitha BA; Shrivastava P; Serkad CPVK; Kaur T; Eshwaraiah MS; Tollenaar RAEM; van de Velde CJH; Seynaeve CMJ; Bakre M; Kuppen PJK
Breast Cancer Res; 2023 Apr; 25(1):40. PubMed ID: 37060036
[TBL] [Abstract][Full Text] [Related]
11. Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients.
Attuluri AK; Serkad CPV; Gunda A; Ramkumar C; Basavaraj C; Buturovic L; Madhav L; Naidu N; Krishnamurthy N; Prathima R; Kanaldekar S; Bakre MM
BMC Cancer; 2019 Mar; 19(1):249. PubMed ID: 30894144
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.
Gunda A; Eshwaraiah MS; Gangappa K; Kaur T; Bakre MM
Breast Cancer Res Treat; 2022 Nov; 196(2):299-310. PubMed ID: 36085534
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
